CrCest Study in Primary Mitochondrial Disease

Enrolling by invitationOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Mitochondrial Diseases
Interventions
DIAGNOSTIC_TEST

Creatine Chemical Exchange Saturation Transfer (CrCEST) Imaging Sequence

CrCEST be used to assess creatine distribution and concentrations in muscle (lower extremity), both at rest and after recovery from a brief foot-pedal depression exercise

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
lead

Children's Hospital of Philadelphia

OTHER